Head-to-head comparison
Hims & Hers vs NiceRx
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Mass-market app-first program with nationwide polish — tirzepatide pricing disclosure lags the ranking.
$199/mo sema
Marked down on: Tirzepatide pricing inconsistently disclosed
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Desk Score
NiceRx offers compounded semaglutide at $199/month and compounded tirzepatide at $299/month, each with a discounted first month, and prints the standing rate beside the promotional one on every card.
$199/mo sema · $299/mo tirz · Verified August 2026
Marked down on: New York was dropped from the service area since our last read, with no notice anywhere on the site; also unavailable in Alaska, Mississippi, New Jersey and Kansas
Hims & Hers takes this head-to-head with the higher Desk Score, 79/100 (C+) against 78/100 (C+) for NiceRx. NiceRx still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Hims & Hers
79/100
C+
NiceRx
78/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Hims & Hers | NiceRx |
|---|---|---|
| Semaglutide | $199/mo$199/mo | $199/mo$199/mo month-to-month (compounded); $99 for the first month |
| Tirzepatide | Not listed on Hims & Hers's site | $299/mo$299/mo month-to-month (compounded); $199 for the first month |
| Coverage | All 50 states | 45 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | People who want a familiar consumer-brand app experience and don't need tirzepatide. | Patients seeking batch-tested compounded GLP-1 with transparent entity disclosure. |
| Desk Score | 79/100C+ | 78/100C+ |
The verdict
Desk pick — Hims & HersHims & Hers takes this head-to-head with the higher Desk Score, 79/100 (C+) against 78/100 (C+) for NiceRx. NiceRx still holds its ground where its strengths line up with yours.
Choose Hims & Hers if…
People who want a familiar consumer-brand app experience and don't need tirzepatide.
$199/mo sema · All 50 states
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Choose NiceRx if…
Patients seeking batch-tested compounded GLP-1 with transparent entity disclosure.
$199/mo sema · $299/mo tirz · 45 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Hims & Hers · NiceRx.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Hims & Hers
- CoreAge Rx vs NiceRx
- Hims & Hers vs Ondra Health
- HealthRX vs NiceRx
- Hims & Hers vs Vaylen
- NiceRx vs RestorLife Med
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.